Subcutaneous (subq) injection
Plain-language patient-community terms — plateau, microdosing, switching.
Definition
Injection into the fatty layer just below the skin (not into muscle). All FDA-approved injectable GLP-1 receptor agonists — Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza, Trulicity — use subq dosing. Approved injection sites: abdomen (≥2 inches from the navel), front of thigh, or back of upper arm. Rotate weekly to reduce lipohypertrophy. Inject at room temperature for less discomfort.
Wegovy dose-ladder cheat sheet →
Definition curated by Weight Loss Rankings — sourced from FDA labels and peer-reviewed PubMed literature, never AI-generated summaries.
Related terms in Patient experience
Looking for more depth?
- Wegovy dose-ladder cheat sheet
- Browse the full GLP-1 glossary (71 terms across 8 categories)
- Research articles — primary-source deep dives
- Tools and calculators
- Compare GLP-1 telehealth providers